Skip to main content

Hadlima Support Group

Latest news

US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon Hadlima (adalimumab-bwwd) Injection

INCHEON, Korea & JERSEY CITY, N.J.--(BUSINESS WIRE) May 27, 2025 – Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE:…

Read more news

Ask a question

To post your own question to our community, sign in or create an account.